Allergan plc announced on Monday it recorded a loss per share of $0.97 in the fourth quarter of 2019, improving from a loss per share of $12.83 in the same period in 2018. Similarly, the Irish-based pharmaceutical company had an operating loss of $276 million, up from $5.38 billion in the fourth...
European Commission announced on Friday it greenlighted biopharmaceutical company AbbVie Inc's purchase of pharmaceutical company Allergan Plc.
EU's competition commissioner Margrethe Vestager said the acquisition "will increase the choice of treatments and offer better prices for...
Purchasers of Namenda, an Alzheimer's drug made by Allergan Plc, requested on Tuesday that a judge in United States District Court in Manhattan confirms their previously agreed upon $750 million settlement with the drugmaker over its violations of antitrust laws.
The purchasers' attorneys...
Allergan Plc's total net revenue for the third quarter of fiscal 2019 landed at $4.05 billion, improving by 3.6% from the same period a year ago, the company announced on Tuesday.
The company's operating loss was $597 million, representing a 331.7% plunge from the third trimester of 2018....
Pharmaceutical companies Endo International Plc and Allergan Plc are nearing a settlement with two of the United States' counties in a landmark opioid crisis case, the Wall Street Journal reported. According to the sources familiar with the matter, the companies would pay $10 million and $5 million,...
Pharmaceutical giant Allergan Plc on Tuesday reported that its financial results in the second quarter of 2019 stood at $4.09 billion, 0.8% lower year-over-year. The company also recorded $1.26 billion in operating loss, which amounts to $5.37 loss per share. This deficit was partially caused by...
Biopharmaceutical company AbbVie Inc. will acquire pharmaceutical giant Allergan Plc for roughly $63 billion in a cash-and-stock deal, the former announced in a press release on Tuesday.
Under the terms of the deal, Allergan shareholders will receive 0.8660 AbbVie shares and $120.30 in cash...
Pharmaceutical giant Allergan Plc announced on Tuesday a 2% annual drop in revenue, with the figure reaching $3.6 billion in the first quarter of 2019. The company's losses per share amounted to $7.25, significantly worse than the $0.99 loss per share seen 12 months ago. Allergan said its operating...
American pharmaceutical company Allergan Plc reported on Tuesday the revenue for the fourth quarter of 2018 stood at $4.08 billion, down 6% compared to the same quarter of 2017. Company's loss per share stood at $12.83 in the last three months of the year, down 30% compared to the...
American pharmaceutical company Allergan Plc reported on Tuesday its financial results for the third quarter of 2018, announcing loss per share of $0.11. The company said its revenue reached a figure of $3.91 billion, decreasing 3% year over year, while its operating income amounted to $257.5...
This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.
